Tech Company Inital Public Offerings

Coherus BioSciences IPO

Coherus BioSciences, operating out of Redwood City, offered its shares in an initial public offering on 11/7/2014.

Transaction Overview

Announced On
11/7/2014
Transaction Type
IPO
Amount
$85,050,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
333 Twin Dolphin Dr. 600
Redwood City, CA 94065
USA
Email Address
Not Recorded
Overview
Coherus Biosciences is a leading developer of high-quality biosimilar therapeutics with a robust biosimilar pipeline aimed to improve biologic drugs access.
Profile
Coherus BioSciences LinkedIn Company Profile
Social Media
Coherus BioSciences Company Twitter Account
Company News
Coherus BioSciences News
Facebook
Coherus BioSciences on Facebook
YouTube
Coherus BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dennis Lanfear
  Dennis Lanfear LinkedIn Profile  Dennis Lanfear Twitter Account  Dennis Lanfear News  Dennis Lanfear on Facebook
Chief Financial Officer
Jean-Frederic Viret
  Jean-Frederic Viret LinkedIn Profile  Jean-Frederic Viret Twitter Account  Jean-Frederic Viret News  Jean-Frederic Viret on Facebook
Chief Medical Officer
Barbara Finck
  Barbara Finck LinkedIn Profile  Barbara Finck Twitter Account  Barbara Finck News  Barbara Finck on Facebook
Chief Technical Officer
Peter Watler
  Peter Watler LinkedIn Profile  Peter Watler Twitter Account  Peter Watler News  Peter Watler on Facebook
Executive Vice President
Vince Anicetti
  Vince Anicetti LinkedIn Profile  Vince Anicetti Twitter Account  Vince Anicetti News  Vince Anicetti on Facebook
Executive Vice President
Vladimir Vexler
  Vladimir Vexler LinkedIn Profile  Vladimir Vexler Twitter Account  Vladimir Vexler News  Vladimir Vexler on Facebook
VP - Bus. Development
Erik Wiberg
  Erik Wiberg LinkedIn Profile  Erik Wiberg Twitter Account  Erik Wiberg News  Erik Wiberg on Facebook
VP - Sales
Michael Fleming
  Michael Fleming LinkedIn Profile  Michael Fleming Twitter Account  Michael Fleming News  Michael Fleming on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/7/2014: H2O venture capital transaction
Next: 11/7/2014: LumaStream venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary